IPP Bureau
IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach
By IPP Bureau - April 27, 2026
The deal signals a clear push to expand access to care in underserved regions
Vision 360 brings academia, industry together to advance ophthalmic therapies
By IPP Bureau - April 25, 2026
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
DSS Imagetech to host webinar series on advanced imaging technologies
By IPP Bureau - April 25, 2026
The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations
IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration
By IPP Bureau - April 25, 2026
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
By IPP Bureau - April 25, 2026
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh
By IPP Bureau - April 25, 2026
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement
By IPP Bureau - April 25, 2026
The summit brought together over 150 doctors, researchers, and practitioners worldwide
ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre
By IPP Bureau - April 25, 2026
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform
By IPP Bureau - April 25, 2026
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem
By IPP Bureau - April 25, 2026
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens
By IPP Bureau - April 25, 2026
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"
By IPP Bureau - April 25, 2026
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1
By IPP Bureau - April 25, 2026
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples
By IPP Bureau - April 24, 2026
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
New genomics clinic by Fortis Hospitals targets early disease detection
By IPP Bureau - April 24, 2026
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
